Skip to Content
  1. Authors
  2. Karen Andersen

Karen Andersen

Karen Andersen, CFA, is a healthcare strategist for Morningstar.

Latest

Morningstar generic-pharmaceuticals analyst Brian Laegeler discusses the outlook for generic biologics in the U.S. given a strong branded-drug lobby and complex manufacturing processes.